United States
Australia
Brazil
Canada
Germany
Ireland
Japan
Mexico
New Zealand
Philippines
South Africa
United Kingdom
Under the Surface Podcast
Similar topics: drug and discovery
Chart positions today · India
Not on the United States charts we track today.
Not on the United Kingdom charts we track today.
Not on the Canada charts we track today.
Not on the Australia charts we track today.
Not on the Germany charts we track today.
Not on the Brazil charts we track today.
Not on the Mexico charts we track today.
Not on the New Zealand charts we track today.
Not on the Ireland charts we track today.
Not on the India charts we track today.
Not on the Japan charts we track today.
Not on the Philippines charts we track today.
Not on the South Africa charts we track today.
If you like Drug Discovery AI Talk, try…
Tech Law Talks
Similar topics: discovery and enabled
The True Blue Podcast - AI Tech News, Education, and Perspective
Similar topics: talk and news
Tech and Drugs - Podcast
Similar topics: drug and discovery
Crackdown
Similar topics: drug and research
The Late Debate
Similar topics: drug and ai
Ranking history · India
Latest daily rankings: Oct 21. New rankings will appear after the next update.
Recent history only — this show has no current ranking on the News, India chart. These are recorded positions from the last 7 days, not current rankings.
Position on the News, India combined chart over the last 7 days. Toggle platforms to compare their positions. Lower rank numbers are better.
View as table
| Date | Combined Rank | Apple Podcasts |
|---|---|---|
| Oct 21 | — | — |
| Oct 19 | #192 | #192 |
Latest episodes
-
#78. From Too Few to Too Many
October 16, 2026 · 22 minAI can now generate millions of molecules, thousands of drug targets, and entire scientific manuscripts in hours — but our capacity to validate any of it hasn't kept pace. This episode walks through the trust crisis in AI drug discovery…
-
Virtual Biology's Reality Check
October 9, 2026 · 26 minBiohub's Virtual Biology Initiative just expanded to $1.8 billion — backed by the DOE, NIH, Google DeepMind, Isomorphic Labs, and Meta — to build the data foundations for predictive AI in biology. But a new perspective argues the field is…
-
#76. AI's Phase III Moment
October 2, 2026 · 22 minOn September 10, 2026, Insilico Medicine dosed the first patient in the Phase III GENESIS-IPF-3 trial of rentosertib (ISM001-055) for idiopathic pulmonary fibrosis - the first drug with both an AI-discovered target and an AI-designed…
-
#75. The AI Patent Landscape 2026
September 25, 2026 · 21 minIn this episode, we examine how AI-native biotechnology companies are reshaping drug discovery through the lens of their intellectual-property portfolios. The evidence suggests that these firms are becoming significantly more productive at…
-
#74. Is Drug Discovery AI Safe?
September 18, 2026 · 21 minIn this podcast, we study how integrating agentic AI into autonomous wet labs promises rapid therapeutic innovation, while connecting autonomous models directly to physical lab instruments creates critical security risks. These range from…
Show 7 more episodesShow fewer episodes
-
#73. The Triumph of Daraxonrasib
September 11, 2026 · 19 minFor decades, KRAS stood as oncology’s archetypal “undruggable” target—a powerful cancer driver with no obvious pocket for conventional medicines to grasp. This episode explores how molecular-glue drugs such as daraxonrasib overturn that…
-
#72. 2026 Emerging Trends
September 4, 2026 · 24 minIn this podcast, we show a pivotal shift in 2026 for AI drug discovery toward integrated, AI-native R&D systems that move beyond simple algorithmic tasks to form closed-loop learning environments. In this new phase, the industry focuses…
-
#71. Magic Wands
August 28, 2026 · 24 minIn this episode, we critically examine whether AI drug discovery is solving the hardest problems in medicine—or simply making the easier ones faster. At the center of the discussion is Daphne Koller’s argument that the industry has…
-
#70. Beyond AlphaFold
August 24, 2026 · 23 minIn this episode, we venture beyond protein structure prediction into the messy, stochastic reality of modeling the virtual cell. We examine why biology still lacks an AlphaFold-like solution for predicting the behavior of entire cells and…
-
#69. CollaboFest
August 7, 2026 · 23 minWhat if we could turn a spark of biological insight into a real-world, life-saving treatment? That is the core mission of CollaboFest, an innovative initiative designed to break down the slow, traditional bottlenecks of drug discovery…
-
#68. Molecular Glues in Therapy
July 31, 2026 · 22 minIn this episode, we explore the rapid evolution of molecular glues, a breakthrough in targeted protein degradation that stabilizes protein interactions to treat previously incurable diseases. Historically discovered by chance, this field…
-
#67. Does Size Matter?
July 24, 2026 · 21 minIn this episode, we examine whether increasing the size and depth of neural networks truly enhances molecular property prediction compared to traditional machine learning. A recent study reveals that classical models using chemical…
About the show
Late-breaking advances in AI-enabled drug discovery, including news, research progress, market trends, and interviews